HANCHORBIO
Live / Registered — Registered (as of 21 Mar 2023)
What this means for you
Registered since 21 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90772552
- Registration number
- 7003113
- Mark type
- Design + words
- Filed
- 14 Jun 2021
- Published for opposition
- 03 Jan 2023
- Registered
- 21 Mar 2023
- Attorney of record
- Joe McKinney Muncy
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products and medicines for the treatment of cancers or autoimmune diseases for human use; Reagents for medical diagnostics; Therapeutic reagents for promoting hair growth; Vaccines for human use; Pharmaceutical reagents for medical use, namely, to enhance immunity; Anti-cancer reagents and medicines; Image-forming reagents for medical diagnostics; Western medicines for treating cancers or autoimmune diseases; Chinese medicines for treating cancers or autoimmune diseases; Anti-viral reagents and medicines for treating cancers or autoimmune diseases; Biological reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Protein reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Chemical reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Biological tissue culture reagents for medical therapeutic use for the treatment of cancers or autoimmune diseases; Testing chemicals for medical therapeutic use for the treatment of cancers or autoimmune diseases; Diagnostic reagents for medical therapeutic use; Biomarker diagnostic reagents for medical therapeutic use; Nutritional supplements; Biological reagents for veterinary use
- Class 035 — Advertising and business services: retail and wholesale store services featuring pharmaceutical products; retail and wholesale store services featuring western medicines; retail and wholesale store services featuring Chinese medicines; retail and wholesale store services featuring nutritional supplements; retail and wholesale store services featuring medical equipment
- Class 042 — Scientific and technological services: Providing services for biomedical research and development, namely, producing biological medicines; Biological research; Bacteriological research; Providing experimental medicines sample testing and diagnostic services for others for clinical research purposes; Providing reagent sample testing and diagnostic services for others for clinical research purposes; Clinical testing of pharmaceutical medicines for others; Scientific research and analysis of experimental medicines or reagents; Medical research; Product research and development on behalf of other parties; Technical research in the field of pharmaceutical studies; Research for technological programs in the nature of biological drug design; Technical writing, namely, writing of technological documents; industrial analysis and research services; Rental of laboratory equipment for experiments; Service for scientific laboratories; Scientific research; Technological consultancy in the field of biological protein engineering; Scientific research in the field of biological/biomedical protein design and engineering; technical research in the field of biological/biomedical protein design and engineering
Owner
- HanchorBio Inc., Taipei City, TW
- HanchorBio Inc., Taipei City, TW
- HanchorBio Inc., Taipei City, TW
Prosecution history
- 21 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 19 Jan 2023 — WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
- 17 Jan 2023 — TEAS DELETE 1(B) BASIS RECEIVED
- 03 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Jan 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 03 Jan 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Jan 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jan 2023 — PUBLISHED FOR OPPOSITION
- 14 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Nov 2022 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 22 Nov 2022 — ASSIGNED TO LIE
- 15 Nov 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Nov 2022 — ELECTRONIC RECORD REVIEW COMPLETE